MCM
RNAM

MAI Capital Management’s Avidity Biosciences RNAM Stock Holding History

MAI Capital Management’s Portfolio RNAM Stock Details RNAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1
Closed -$73 – 5120
2025
Q4 		$73 Buy
+1
New +$65 ﹤0.01% 4202

Other funds holding RNAM

CC
Corsicana & Co Corsicana, Texas $158M AUM

MAI Capital Management's RNAM Position: Q1 2026 in Review

MAI Capital Management sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 1 share — an estimated $73 sold.

MAI Capital Management first reported a position in RNAM in Q4 2025 and held it in 1 quarter. The position peaked at $73 in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

  • MAI Capital Management reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
  • MAI Capital Management sold 1 Avidity Biosciences share in Q1 2026, an estimated $73.
  • MAI Capital Management first reported a position in Avidity Biosciences in Q4 2025 and held it in 1 quarter.
  • MAI Capital Management's Avidity Biosciences position peaked at $73 in Q4 2025.
  • 1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on MAI Capital Management's 13F filing for Q1 2026, filed 15 May 2026.